Bavarian Nordic

bavarian nordic is a fully integrated biotechnology company focused on the development of innovative and safe therapies against cancer and infectious diseases. using our live virus vaccine platform technology, mva-bn®, we have created a diverse portfolio of proprietary and partnered product candidates intended to improve the health and quality of life for children and adults. we supply our imvamune® non-replicating smallpox vaccine to the u.s. strategic national stockpile and other government stockpiles. the vaccine is approved in the european union (under the trade name imvanex®) and in canada. registration studies are currently underway in the u.s. in addition to our long-standing collaboration with the u.s. government on the development of imvamune® and other medical countermeasures, our infectious disease pipeline comprises a proprietary rsv program as well as vaccine candidates for ebola, hpv, hbv and hiv, which are developed through a strategic partnership with janssen. additiona